Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
...
Next
(30)
•••
jimmyhorizon
X
View Profile
View Bullboard History
Post by
jimmyhorizon
on May 22, 2023 4:29pm
Update
They no longer pretend that the big breakthrough is around the corner. They probably haven't even lied since their abbvie announcement (which was full of lies). They are
...more
(80)
•••
bealert
X
View Profile
View Bullboard History
Post by
bealert
on May 20, 2023 7:16pm
Health Canada Not Going After Hydroquinone
Someone's post was removed when they questioned why Health Canada is not going after Hydroquinone Here is what a google search says: Skin lightening products containing hydroquinone are not
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(2138)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on May 19, 2023 10:25am
Health Canada seizes skin whitening products
https://www.newswire.ca/news-releases/public-advisory-health-canada-warns-about-multiple-unauthorized-health-products-that-may-pose-serious-health-risks-839635601.html
(1167)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on May 18, 2023 2:35am
RE:RE:RE:Science Potential: Biomimicry
Sirona Biochem $1,563,600 debenture private placement 2023-05-17 20:27 ET - Private Placement - Debenture The TSX Venture Exchange has accepted for filing documentation
...more
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Post by
forhandlaren
on May 16, 2023 10:05am
Pretty good rundown of the company and it's potential
Later bloomer... I just find this video. Nevertheless, it's a pretty good rundown of the company and it's potential. {^youtubevideo|(width)425|(height)264|(rel)False|(url)https://www.youtube
...more
(38)
•••
Turtle4
X
View Profile
View Bullboard History
Comment by
Turtle4
on May 16, 2023 10:01am
RE:Science Potential: Biomimicry
Management focuses on long-term profit. That is why they did not want a high upfront for 1067 with which they could drive other projects / research. Management would rather do that much much later
...more
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Post by
forhandlaren
on May 16, 2023 9:17am
Science Potential: Biomimicry
From Investor Presentation back in 2015 transformed into text: Sirona's Glycoprotein program - - Cosmetic Active Ingredients - - - - Anti-aging - - - - Protection & Regeration
...more
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on May 16, 2023 12:25am
RE:SBM mgmt, get on with it
Yes. If people want to pay the price for evidence based combination products and royalties remain. It's a win-win.
(2138)
•••
lscfa
X
View Profile
View Bullboard History
Post by
lscfa
on May 15, 2023 9:17pm
SBM mgmt, get on with it
An emerging trend in the skin lightening products market is the rising popularity of multi-functional products that offer multiple benefits such as sun protection, anti-aging, and skin brightening
...more
(33)
•••
SleepyHoward
X
View Profile
View Bullboard History
Post by
SleepyHoward
on May 15, 2023 5:42am
Twitter
https://twitter.com/SironaBiochem/status/1658034942138372098
(80)
•••
bealert
X
View Profile
View Bullboard History
Post by
bealert
on May 13, 2023 1:24pm
MOMENTUM PR FIRM
I noticed that Momentum's last press release was on Jan 16 this year. Then I noticed the following anonymous director press release. These are starting to look suspicious. Sirona
...more
(6)
•••
biofool
X
View Profile
View Bullboard History
Comment by
biofool
on May 13, 2023 3:29am
RE:Back to no trading
The pumpers dump their free shares. Guess who is the main pumper here. They use retails at least twice a year as their ATM . They need this money, probably because they don't have another income.&
...more
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Post by
forhandlaren
on May 12, 2023 10:49am
TFC-1067 NPV back in 2017
I have saved a few Investor Presentations and in the one from Nov 2017 the company states the following about TFC-1067 (pre clinical trial): "Our discounted cash flow models estimate a NPV of
...more
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on May 12, 2023 10:29am
RE:RE:A better runway
The compound will be a 'must-have' for everyone that target the same market segment. Hard to compete once one partner has a license. I think this would maximize the market. I also like the
...more
Prev
...
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >